IMC Chicago
PRCT icon

IMC Chicago’s Procept Biorobotics PRCT Stock Holding History

IMC Chicago’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553K Buy
24,495
+4,598
+23% +$115K ﹤0.01% 4528
2026
Q1 		$498K Buy
19,897
+7,635
+62% +$215K ﹤0.01% 4050
2025
Q4 		$386K Buy
+12,262
New +$407K ﹤0.01% 3643

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

IMC Chicago's PRCT Position: Q2 2026 in Review

IMC Chicago increased its Procept Biorobotics (PRCT) stake by 23% in Q2 2026, buying an estimated $115K and bringing the position to 24,495 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #4528.

IMC Chicago first reported a position in PRCT in Q4 2025 and has held it in 3 quarters since. 98 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • IMC Chicago held 24,495 shares of Procept Biorobotics worth $553K as of Q2 2026.
  • IMC Chicago bought 4,598 Procept Biorobotics shares in Q2 2026, an estimated $115K.
  • Procept Biorobotics made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4528 holding.
  • IMC Chicago first reported a position in Procept Biorobotics in Q4 2025 and has held it in 3 quarters since.
  • 98 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.